Earnings Summary

Shockwave Medical, Inc.’s revenue jumped 40.93% since last year same period to $202.98Mn in the Q4 2023. On a quarterly growth basis, Shockwave Medical, Inc. has generated 9.12% jump in its revenue since last 3-months.

Shockwave Medical, Inc.’s net profit fell -68.56% since last year same period to $44.31Mn in the Q4 2023. On a quarterly growth basis, Shockwave Medical, Inc. has generated 26.64% jump in its net profits since last 3-months.

Shockwave Medical, Inc.’s net profit margin fell -77.69% since last year same period to 21.83% in the Q4 2023. On a quarterly growth basis, Shockwave Medical, Inc. has generated 16.06% jump in its net profit margins since last 3-months.

Shockwave Medical, Inc.’s price-to-earnings ratio after this Q4 2023 earnings stands at 84.85.

Shockwave Medical, Inc.’s earning per share (EPS) estimates for the current quarter stand at 0.98 - a 10.11% jump from last quarter’s estimates.

Shockwave Medical, Inc.’s earning per share (EPS) estimates for the current year stand at 0.98.

Shockwave Medical, Inc.’s earning per share (EPS) fell -1.69% since last year same period to 1.16 in the Q4 2023. This indicates that the Shockwave Medical, Inc. has generated -1.69% annual rate of fall in its earning per share (EPS) in the last 4 quarters.

Return on assets (ROA) indicates the profitability of the company in relation to its total assets. This ratio tells the financial health of the company. The higher the ROA, the better the company’s financial health. If any company has a ROA in the range of 5% to 20% - it is generally considered good. ROA above 20% is generally considered excellent. Shockwave Medical, Inc.’s return on assets (ROA) stands at 0.09.

The Return On Equity ratio indicates a company’s ability to turn equity capital received from shareholders into profits. ROE highlights the efficiency of equity capital in running the business. Generally, a return on equity in double digits is considered good. Shockwave Medical, Inc.’s return on equity (ROE) stands at 0.25.